IPRIPR2025-00054Terminated-Adverse Judgment
Dr. Falk Pharma GMBHv.Ellodi Pharmaceuticals LP
IPR challenge of US 11246828.
Type
IPR
Filed
Oct 24, 2024
Instituted
Jun 3, 2025
Decided
Jan 23, 2026
Patent
Application
16821464
Inventor
Stephen PERRETT et al
Granted
Feb 15, 2022
01
Timeline
3 milestones
2024-10-24Petition filed
2025-06-03Institution
2026-01-23Terminated
02
Parties & counsel
Petitioner
Dr. Falk Pharma GMBH
Counsel
Luman, Nathanaelet al
Patent Owner
Ellodi Pharmaceuticals LP
Counsel
Sukduang, Sanyaet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →